Skip to content

Clinical trials

Phase 3 Autoimmune Diseases trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 3 Country / region: Israel Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20111
20131
20151
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Immunovant Sciences GmbH2
AstraZeneca1
Baxalta now part of Shire1
Eli Lilly and Company1
Human Genome Sciences Inc.1
Human Genome Sciences Inc., a GSK Company1
Novartis Pharmaceuticals1
X4 Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases9
Immune System Diseases3
Lupus Erythematosus, Systemic3
Graves Ophthalmopathy2
Autoimmune Diseases of the Nervous System1
Barth Syndrome1
Connective Tissue Diseases1
Demyelinating Diseases1
Lung Diseases, Interstitial1
Nervous System Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.